Why the study?
Does a single dose of aspirin decrease platelet uptake and improve patency of Dacron vascular grafts in a baboon model?
Does a single dose of aspirin decrease platelet uptake and improve patency of Dacron vascular grafts in a baboon model?
In a baboon model, a single dose of aspirin effectively reduces platelet uptake on Dacron vascular grafts and improves early graft patency.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for early graft patency; leaves open translation to human vascular procedures.
The influence of a single dose of aspirin (5.4-7.4 mg/kg) on platelet uptake on 4-mm Dacron interposition grafts was studied in a baboon model using gamma camera scanning for 111-Indium labeled platelets. In vitro assessment of platelet function after aspirin administration revealed that in the baboon, as in the human, aspirin abolished arachidonic acid-induced platelet aggregation, prolonged the lag time between exposure to collagen and aggregation, and decreased plasma thromboxane B2 levels. Aspirin also prolonged the template bleeding time. Scans for 111-Indium labeled platelets revealed that pretreatment with a single dose of aspirin decreased platelet uptake on 4-mm Dacron carotid interposition grafts. This decrease in platelet uptake was associated with a significant improvement in 2-hour graft patency and with a trend toward improved 2-week patency.
No takes yet. Share an insight, caveat, or question.
Mackey et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: